AU2002249741A1 - Use of a tnf inhibitor for the treatment of low back pain - Google Patents

Use of a tnf inhibitor for the treatment of low back pain

Info

Publication number
AU2002249741A1
AU2002249741A1 AU2002249741A AU2002249741A AU2002249741A1 AU 2002249741 A1 AU2002249741 A1 AU 2002249741A1 AU 2002249741 A AU2002249741 A AU 2002249741A AU 2002249741 A AU2002249741 A AU 2002249741A AU 2002249741 A1 AU2002249741 A1 AU 2002249741A1
Authority
AU
Australia
Prior art keywords
treatment
back pain
low back
tnf inhibitor
tnf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002249741A
Inventor
Kjell Olmarker
Bjorn Rydevik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A+ Science AB
Original Assignee
A+ Science Invest AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A+ Science Invest AB filed Critical A+ Science Invest AB
Publication of AU2002249741A1 publication Critical patent/AU2002249741A1/en
Abandoned legal-status Critical Current

Links

AU2002249741A 2001-04-06 2002-04-05 Use of a tnf inhibitor for the treatment of low back pain Abandoned AU2002249741A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0101256-6 2001-04-06

Publications (1)

Publication Number Publication Date
AU2002249741A1 true AU2002249741A1 (en) 2002-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
AU2001259758A1 (en) Interleukin-1 inhibitors in the treatment of diseases
AU2003298043A1 (en) Surface treatment of medical device
AU2002339157A1 (en) Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2001279540A1 (en) Dental splint
AU2003235798A1 (en) Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
AU2002341321A1 (en) Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
GB0213869D0 (en) The treatment of pain
AU3896900A (en) Treatment of pain
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002359177A1 (en) Use of interleukin-6 for treatment of obesity
AU2003294941A1 (en) Combinations of a vanilloid antagonist and an nsaid for the treatment of pain
AU2002249741A1 (en) Use of a tnf inhibitor for the treatment of low back pain
AU2002210286A1 (en) Medicine intended for treatment of multiple sclerosis
AU2003240446A1 (en) Use of mob-5 in pain
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
AU2002357046A1 (en) Combination therapy comprising a cyclooygenase-2 inhibitor
HUP0402664A3 (en) 2-indanylamino derivatives for the therapy of chronic pain
AU2003213349A1 (en) Therapeutic agent for pain
GB0128122D0 (en) Therapeutic use
GB0123991D0 (en) New therapeutic use
AU2002251630A1 (en) Use of tnf inhibitor for treatment of whiplash associated disorder
AU2002327697A1 (en) Compounds for the treatment of pain
AU2002318205A1 (en) Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines